NCT07779395 Artificial Intelligence-Supported Pressure Injury Prevention and Care in Intensive Care Patients
| NCT ID | NCT07779395 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Yildirim Beyazıt University |
| Condition | Pressure Injury |
| Study Type | INTERVENTIONAL |
| Enrollment | 174 participants |
| Start Date | 2026-03-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 174 participants in total. It began in 2026-03-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effect of an artificial intelligence-supported mobile application, PRESS AI, on pressure injury prevention and nursing care in adult intensive care patients. The application supports nurses in pressure injury risk assessment, wound assessment and staging, and selection of appropriate prevention and care interventions. The study compares the incidence of hospital-acquired pressure injuries before and after the implementation of PRESS AI. During the pre-intervention period, patients receive routine pressure injury prevention and nursing care. During the intervention period, nurses use PRESS AI together with an integrated pressure injury prevention and care algorithm to support clinical assessment and care planning.
Eligibility Criteria
Inclusion Criteria: * Aged 18 years or older. * Hospitalized in the Anesthesiology and Reanimation Intensive Care Unit of Ankara University Ibni Sina Research and Application Hospital during the pre-intervention or intervention period. * Written informed consent provided by the patient or, when the patient lacks decision-making capacity, by the patient's legally authorized representative. Exclusion Criteria: * Refusal to participate by the patient or legally authorized representative, or withdrawal of previously provided consent. * Missing essential follow-up data required to assess the development of pressure injuries.
Contact & Investigator
Hilal Tüzer, PhD
PRINCIPAL INVESTIGATOR
Ankara Yildirim Beyazıt University
Frequently Asked Questions
Who can join the NCT07779395 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pressure Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07779395 currently recruiting?
Yes, NCT07779395 is actively recruiting participants. Contact the research team at gurbet.bdr@gmail.com for enrollment information.
Where is the NCT07779395 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07779395 clinical trial?
NCT07779395 is sponsored by Ankara Yildirim Beyazıt University. The principal investigator is Hilal Tüzer, PhD at Ankara Yildirim Beyazıt University. The trial plans to enroll 174 participants.